BHSRX
Price
$62.44
Change
+$0.33 (+0.53%)
Updated
Feb 4 closing price
Net Assets
6.49B
FSPHX
Price
$28.43
Change
-$0.19 (-0.66%)
Updated
Feb 3 closing price
Net Assets
6.28B
Interact to see
Advertisement

BHSRX vs FSPHX

Header iconBHSRX vs FSPHX Comparison
Open Charts BHSRX vs FSPHXBanner chart's image
BlackRock Health Sciences Opps R
Price$62.44
Change+$0.33 (+0.53%)
VolumeN/A
Net Assets6.49B
Fidelity Select Health Care
Price$28.43
Change-$0.19 (-0.66%)
VolumeN/A
Net Assets6.28B
BHSRX vs FSPHX Comparison Chart in %
View a ticker or compare two or three
VS
BHSRX vs. FSPHX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHSRX is a Buy and FSPHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BHSRX (6.49B) and FSPHX (6.28B) have equal amount of cash in the bank . FSPHX pays higher dividends than BHSRX: FSPHX (0.43) vs BHSRX (0.10). BHSRX was incepted earlier than FSPHX: BHSRX (14 years) vs FSPHX (45 years). BHSRX (1.45) is less costly to investors than FSPHX (0.63). BHSRX is a more actively managed with annual turnover of: 43.00 vs. FSPHX (40.00). FSPHX has a lower initial minimum investment than BHSRX: FSPHX (0) vs BHSRX (100). FSPHX annual gain was more profitable for investors over the last year : -0.62 vs. BHSRX (-3.16). FSPHX (-14.42) and BHSRX (-14.83) have equivalent 5 years return.
BHSRXFSPHXBHSRX / FSPHX
Total Expense Ratio1.440.63229%
Annual Report Gross Expense Ratio1.450.63230%
Fund Existence14 years45 years-
Gain YTD0.6770.000-
Front LoadN/AN/A-
Min. Initial Investment1000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.49B6.28B103%
Annual Yield % from dividends0.100.4323%
Returns for 1 year-3.16-0.62510%
Returns for 3 years-0.720.66-109%
Returns for 5 years-14.83-14.42103%
Returns for 10 years51.8461.3185%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FASEX55.820.52
+0.94%
Nuveen Mid Cap Value Opportunities A
REIZX15.300.05
+0.33%
Third Avenue International RE Val Z
TWAAX13.40N/A
N/A
Thrivent International Equity A
BRXCX18.18-0.03
-0.16%
MFS Blended Research Intl Eq C
HCAIX98.58-1.62
-1.62%
Harbor Capital Appreciation Inv